Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abcellera Biologics Inc (NQ: ABCL ) 2.610 +0.100 (+3.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,801,753 Open 2.530 Bid (Size) 2.600 (2) Ask (Size) 2.660 (10) Prev. Close 2.510 Today's Range 2.525 - 2.645 52wk Range 2.400 - 6.055 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday August 20, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 The AI-powered drug discovery process is expected to grow by a 30% CAGR between now and 2030 which should result in approximately 50 novel therapies and generate annual sales in excess of $50 billion... Via Talk Markets Performance YTD -54.45% -54.45% 1 Month -15.81% -15.81% 3 Month -36.03% -36.03% 6 Month -47.27% -47.27% 1 Year -52.63% -52.63% More News Read More AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript August 07, 2024 Via The Motley Fool Topics Earnings Exposures Financial AbCellera Reports Q2 2024 Business Results August 06, 2024 From AbCellera Biologics Inc. Via Business Wire AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines July 31, 2024 From AbCellera Biologics Inc. Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 Via Talk Markets "Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday July 28, 2024 Via Talk Markets Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? July 21, 2024 Via The Motley Fool AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets 3 Biotech Stocks That Can Gain Exponentially By Leveraging AI July 02, 2024 Via Talk Markets AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 June 25, 2024 From AbCellera Biologics Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 Via Talk Markets Down 57%, Is AbCellera Biologics a Buy on the Dip? June 13, 2024 Via The Motley Fool AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 Via Talk Markets AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 May 28, 2024 From AbCellera Biologics Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 Via Talk Markets A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In May 20, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week May 13, 2024 Via Talk Markets 3 Stock Gems Hiding in the Nasdaq May 13, 2024 Via InvestorPlace 5 Of 7 AI Categories Rose, Slightly,Over Past Week May 11, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript May 08, 2024 Via The Motley Fool Topics Earnings Exposures Financial ABCL Stock Earnings: AbCellera Biologics Beats EPS, Misses Revenue for Q1 2024 May 07, 2024 Via InvestorPlace AbCellera Reports Q1 2024 Business Results May 07, 2024 From AbCellera Biologics Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.